Performance of the Academic Research Consortium High Bleeding Risk Criteria in Patients With ST-Segment Elevation Myocardial Infarction: A Single Center Study

  • Duygu Inan
    Department of Cardiology, Basaksehir Cam & Sakura City Hospital, Istanbul, Turkey
  • Ahmet C. Yumurtas
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey
  • Barıs Simsek
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey
  • Ali Palice
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey
  • Eyüp M. Efendioglu
    Faculty of Medicine, Department of Internal Medicine, Gaziantep University, Gaziantep, Turkey
  • Gizem Yuksel
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey
  • Betul Korkmaz
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey
  • Elif G. Vatanoglu
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey
  • Barış Güngör
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey
  • Can Y. Karabay
    Department of Cardiology, University of Health Sciences Dr Siyami Ersek Training and Research Hospital Istanbul, Turkey

説明

<jats:p> We assessed the ability of predicting mortality and total in-hospital bleeding and adverse outcomes by the Academic Research Consortium High Bleeding Risk (ARC-HBR) criteria in ST-segment elevation myocardial infarction (STEMI) patients undergoing primary percutaneous coronary intervention (pPCI). A total of 1441 STEMI patients were recruited: HBR group 354 (25%) patients and non-HBR group of 1087 (75%) patients. A total of 131 patients (9%) had a bleeding complication during hospitalization. The bleeding complications were also categorized according to other conventional bleeding scores. According to these conventional scores, all bleeding categories were associated with HBR. In univariate logistic regression analysis, female gender, diabetes mellitus, hypertension (HT) and HBR were associated with in-hospital bleeding. However, in multivariable analysis only HT (Odds Ratio [OR] 1.528, 95% CI 1.020–2.290; P = .040) and HBR (OR 1.612, 95% CI 1.075–2.428; P = .022) independently predicted total in-hospital bleeding complications. Hospital duration was longer and mortality rate was significantly higher in patients with HBR (OR 8.755, 95% CI 5.864–13.074; P < .01). The ARC-HBR criteria may predict in-hospital bleeding events and adverse outcomes in STEMI patients undergoing pPCI. </jats:p>

収録刊行物

  • Angiology

    Angiology 75 (2), 166-174, 2022-10-29

    SAGE Publications

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ